Biotech

Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis

DEERFIELD, IL: ...

Reimbursement Intelligence: Payers Struggling to Manage Combination Use of Costly Prostate Cancer Therapies

MADISON, NJ: ...

FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System

SAN DIEGO, CA: ...

Sunshine Heart to Present at Upcoming Investor Conferences

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China

PISCATAWAY, NJ: ...

Cornerstone Therapeutics Reports Third Quarter 2012 Financial Results

CARY, NC: ...

TiGenix: Business Update & Financial Highlights for Q3 of 2012

LEUVEN, BELGIUM: ...

Sarepta Therapeutics Announces Third Quarter 2012 Financial Results and Recent Corporate Developments

CAMBRIDGE, MA: Positive 48-Week Results From Phase IIb DMD Study Supports Eteplirsen's Further Development, Regulatory and Manufacturing Activities; Strong Financial Position With Current Cash Balance of $57.4 ...

Alethia Biotherapeutics Receives Notice of a Decision to Grant European Patent for its Siglec-15 Bone Antiresorptive

MONTREAL, QUEBEC: ...

China Pharma Holdings, Inc. to Report Third Quarter of Fiscal Year 2012 Financial Results on November 15, 2012

HAIKOU CITY, CHINA: ...